<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "foscarnet inj VIAL>
<dose><value>90</value>
<value>60</value>
<value>90 - 120</value>
<value>40</value>
<value>40 - 60</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>foscarnet inj VIAL</value>
</drugname><strength><value>24 mg/mL</value>
</strength><frequency><value>Q12H</value>
<value>Q8H  </value>
<value>DAILY</value>
<value>Q8H</value>
</frequency><instruction><value></value>
<value>for 7 days.</value>
</instruction><volume><value>250 mL</value>
<value>500 mL</value>
</volume><units><value>mg/kg</value>
</units><additionalnotes><value>CMV Retinitis. Induction treatment course: 14 to 21 days.</value>
<value>CMV Retinitis. Maintenance dosing.</value>
<value>CMV infections in GI tract</value>
<value>Acyclovir-resistant HSV infection. Treatment for 2 to 3 weeks or until lesions heal.</value>
<value>CMV Retinitis. Maintenance.</value>
<value>Acyclovir-resistant HSV infection. Treatment for 2 to 3 weeks or until lesions heal. Alternate treatment regimen.</value>
</additionalnotes><population><value>ADULT</value>
<value>INFANT / CHILDREN</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3225</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3224</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Usage guidelines. Health Canada Special Access Programme.</value>
</ahsformularystatus><ahfsname><value>Antivirals, Miscellaneous</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>